Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Prolia
Pharma
Which drug price increases led to the most US spending?
Bausch’s Xifaxan topped ICER’s annual list of drugs that had unjustified price increases in 2021 and caused the most additional spending in the U.S.
Kevin Dunleavy
Dec 7, 2022 9:20am
Bushu and Amgen expand Asian contract manufacturing pact
Nov 24, 2021 11:15am
The top 15 blockbuster patent expirations coming this decade
Jul 12, 2021 3:00am
Watchdog sues FDA for stalling on Parkinson's drug warnings
Apr 30, 2019 11:02am
Public Citizen requests FDA black box for Amgen's Prolia
Apr 18, 2019 11:50am
Amgen prices bone drug Evenity on par with rival Tymlos
Apr 16, 2019 12:18pm
